# 0409-3178-02 · Epinephrine Bitartrate, Lidocaine Hydrochloride Injection · Hospira, Inc., a Pfizer Company — FDA drug shortage duration tracker

For 0409-3178-02 · Epinephrine Bitartrate, Lidocaine Hydrochloride Injection · Hospira, Inc., a Pfizer Company, package ndc is 0409-3178-02; generic name is Epinephrine Bitartrate, Lidocaine Hydrochloride Injection; manufacturer is Hospira, Inc., a Pfizer Company; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01; source re-checked 2026-09-10.

- **Package NDC:** 0409-3178-02 _(verified: appears in the quote below)_
- **Generic name:** Epinephrine Bitartrate, Lidocaine Hydrochloride Injection _(verified: appears in the quote below)_
- **Manufacturer:** Hospira, Inc., a Pfizer Company _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Unavailable _(verified: appears in the quote below)_
- **FDA note:** Next Delivery: November 2026; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay _(verified: appears in the quote below)_
- **Initial posting date:** 02/22/2012 _(verified: appears in the quote below)_
- **Last update date:** 08/24/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 5305 _(our reading, not quoted from the source)_
- **Reason for shortage:** Other _(verified: appears in its own passage below)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Anesthesia _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "02/22/2012", "package_ndc": "0409-3178-02", "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection", "contact_info": "844-646-4398", "availability": "Unavailable", "related_info": "Next Delivery: November 2026; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/24/2026", "therapeutic_category": [ "Anesthesia", "Pediatric" ], "dosage_form": "Injection", "presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current"

### Status

> "update_date": "08/24/2026", "therapeutic_category": [ "Anesthesia", "Pediatric" ], "dosage_form": "Injection", "presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current"

### Last update date

> "update_date": "08/24/2026", "therapeutic_category": [ "Anesthesia", "Pediatric" ], "dosage_form": "Injection", "presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current"

### Reason for shortage

> "update_date": "08/24/2026", "therapeutic_category": [ "Anesthesia", "Pediatric" ], "dosage_form": "Injection", "presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current"

### Dosage form

> "update_date": "08/24/2026", "therapeutic_category": [ "Anesthesia", "Pediatric" ], "dosage_form": "Injection", "presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current"

### Therapeutic category

> "update_date": "08/24/2026", "therapeutic_category": [ "Anesthesia", "Pediatric" ], "dosage_form": "Injection", "presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current"

## The same source also states

> "initial_posting_date": "02/22/2012", "package_ndc": "0409-3178-02", "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection", "contact_info": "844-646-4398", "availability": "Unavailable", "related_info": "Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay"

Source: https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-10. Review by: 2026-09-13.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).